UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara, Jr. helped author a clinical trial testing the best treatment for metastatic papillary kidney cancer. The promising results are published in The Lancet.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
Ignacio Saez, assistant professor in the UC Davis Department of Neurological Surgery has been honored with the Edwin Boldrey Award from the San Francisco Neurological Society for his research.
COVID-19 variants spreading across the U.S. are more infectious, cause more serious illness and are more deadly – but wearing a mask and social distancing still protect you, and they are as important as they’ve ever been.
Compared to sociobehavioral studies, biomedical studies typically require more time and visits, tend to be more quantitative, more in-person, and of greater risk
During Heart Failure Awareness Week (Feb. 16-19), nine UC Davis experts will discuss heart failure symptoms, prevention, treatment and more in interactive Facebook Live sessions.
In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, UC San Diego and the County of San Diego are testing the Safer at School Early Alert system to detect SARS-CoV-2 at schools and child care centers.
Health Media Contacts
Find the best contact for health-related media inquiries.
